Table 2 Statistical analyses of HRT+ and HRT− cases
From: Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
HRT+ | HRT− | ||
|---|---|---|---|
Number of cases | 83 | 123 | |
Alive and disease free | 80 | 93 | |
Alive with disease | 2 | 4 | |
Died of melanoma | 1 | 22 | |
Died of other causes | 0 | 4 | |
Cox regression | HR (95% CI) | HR | P -value |
Unadjusted | 0.167 (0.050, 0.555) | 1 | 0.004 |
Adjusted for ulceration | 0.189 (0.057, 0.634) | 1 | 0.007 |
Adjusted for ulceration and primary tumour thickness | 0.136 (0.039, 0.480) | 1 | 0.002 |
Adjusted for ulceration, primary tumour thickness and age | 0.173 (0.048, 0.621) | 1 | 0.007 |
